Skip to content

Comparison of analgesic effects of dexmedetomidine and ketamine in adductor canal block ( for post operative pain relief following unilateral TKR )

Evaluation of analgesic effects of ketamine versus dexmedetomidine as an adjuvant to 0.2% ropivacaine infusion in adductor canal block for post-operative analgesia following unilateral total knee replacement surgery. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062480
Enrollment
44
Registered
2024-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Adductor canal block: All patient undergoing unilateral knee replacement will receive 0.2% ropivacaine as an infusion in adductor canal block for post operative analgesia Control Inter

Sponsors

Dr Sahla Shamsudheen
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: American society of anaesthesiologist physical status I-III

Exclusion criteria

Exclusion criteria: 1) Allergy to local anaesthetics 2) Patient with history of previous knee surgeries 3) Patients with contra indications to spinal anaesthesia 4) Patients with history of chronic analgesic use

Design outcomes

Primary

MeasureTime frame
Number of patients requiring additional opioids following ketamine versus dexmedetomidine as an adjuvant to ropivacaine infusion in adductor canal blockTimepoint: 24 hours post operatively

Secondary

MeasureTime frame
1 )Hemodynamic changes 2 ) To assess motor blockade 3 )Pain on ambulation. 4 )To compare adverse effects like hallucination , nausea , vomiting Timepoint: 4th hourly for 24 hours post operatively

Countries

India

Contacts

Public ContactDr Sahla Shamsudheen

Amrita institute of medical science and research centre

gokuldas75@hotmail.com9847448005

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026